CBD showing potential to reduce lung damage caused by Covid19

Professor Dedi Meiri, Chairman and CSO at CannaSoul said, “MyPlant-Bio’s (Cannasoul’s Subsidiary) Cytokine Storm Assay is a well-established preclinical in-vitro, or practically ex-vivo, assay. It provides an evaluation of Cytokine Storm Syndrome with human peripheral blood mononuclear cells. The goal of this study was to assess the effect of Eybna NT-VRL terpene formulation on cytokine secretion.”

In the early research on the use of cannabis plants like terpenes, many scientists believed that it can give a satisfactory relief from the inflammation caused in the lungs because of COVID-19. “NT-VRL terpene formulation showed significant anti-inflammatory effect which contributed to a functional immunological response in vitro, Healtheuropa quoted Professor Dedi Meiri as saying.”